Charles Schwab Investment Management Inc Crispr Therapeutics Ag Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 724,241 shares of CRSP stock, worth $29.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
724,241
Previous 717,606
0.92%
Holding current value
$29.5 Million
Previous $38.8 Million
12.19%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$323 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$305 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$122 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$121 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$121 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.18B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....